Stock Research for CBIS


Featured Broker: Ally Invest

Get the due diligence for another stock.


CBIS Stock Chart & Research Data

The CBIS chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CBIS chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


CBIS Due diligence Resources & Stock Charts

The CBIS stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View CBIS Detailed Price Forecast - CNN Money CNN View CBIS Detailed Summary - Google Finance
Yahoo View CBIS Detailed Summary - Yahoo! Finance Zacks View CBIS Stock Research & Analysis -

Stock Analysis

TradeIdeas View CBIS Trends & Analysis - Trade-Ideas Barrons View CBIS Major Holders - Barrons
NASDAQ View CBIS Call Transcripts - NASDAQ Seeking View CBIS Breaking News & Analysis - Seeking Alpha
Spotlight View CBIS Annual Report - OTC Report View CBIS OTC Short Report -
TradeKing View CBIS Fundamentals - TradeKing Charts View CBIS SEC Filings - Bar Chart
WSJ View Historical Prices for CBIS - The WSJ Morningstar View Performance/Total Return for CBIS - Morningstar
MarketWatch View the Analyst Estimates for CBIS - MarketWatch CNBC View the Earnings History for CBIS - CNBC
StockMarketWatch View the CBIS Earnings - StockMarketWatch MacroAxis View CBIS Buy or Sell Recommendations - MacroAxis
Bullish View the CBIS Bullish Patterns - American Bulls Short Pains View CBIS Short Pain Metrics -

Social Media Mentions

StockTwits View CBIS Stock Mentions - StockTwits PennyStocks View CBIS Stock Mentions - PennyStockTweets
Twitter View CBIS Stock Mentions - Twitter Invest Hub View CBIS Investment Forum News - Investor Hub
Yahoo View CBIS Stock Mentions - Yahoo! Message Board Seeking Alpha View CBIS Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for CBIS - Insider Cow View Insider Transactions for CBIS - Insider Cow
CNBC View CBIS Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for CBIS - OTC Markets
Yahoo View Insider Transactions for CBIS - Yahoo! Finance NASDAQ View Institutional Holdings for CBIS - NASDAQ

Stock Charts

FinViz View CBIS Stock Insight & Charts - StockCharts View CBIS Investment Charts -
BarChart View CBIS Stock Overview & Charts - BarChart Trading View View CBIS User Generated Charts - Trading View

Latest Financial News for CBIS

Cannabis Science Enters Transition Stage as Trading of the Company’s Shares is Halted; The Company Will Continue to Implement Its Growth Strategy and Resolve All Outstanding Fully Reporting Requirements
Posted on Friday September 06, 2019

IRVINE, CA, Sept. 06, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, announces that it is entering a transition stage as trading of the Company’s shares is halted. Cannabis Science will continue to implement its corporate growth strategy and intends to resolve all outstanding regulatory reporting and filing requirements as it goes through its transition. “I can confirm that I found out yesterday that the trading of Cannabis Science’s shares has been halted by regulatory authorities - clearly the paperwork states ‘due to the financials not being filed as a fully-reporting issuer’.  While this is not a favorable situation, we are already addressing this matter directly with the authorities to protect the interests of our shareholders and stakeholders,” states Raymond C. Dabney, President, C.E.O. and Co-Founder of Cannabis Science.

Cannabis Science Partners With CDN Firm NHS Industries to Launch the CBIS CDN Economic Development Plan; CBIS to Use Its Relations With the Harvard International Phytomedicines and Medical Cannabis Institute and Other Leading Institutions
Posted on Tuesday August 27, 2019

IRVINE, CA, Aug. 28, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce the Company has signed a joint venture agreement with a Canadian public company, NHS Industries, Ltd. NHS Industries (CSE: (NHS), (NNHHF)). The group will focus on job creation, deliver and develop public and private access educational content, and research various delivery platforms for medical cannabinoid-related products and services, all based on the CBIS Economic Development Plan for Canada, (CBIS/CDN EDP). The new Canadian-based partnership will expand Cannabis Science’s existing operations into Canada through its CDN EDP.

Cannabis Science Prepares Announcements for Revenues and Corporate Growth; Finalizing New Asset Partnerships and Acquisitions Targeting Positive Cash Flow in Key Markets Globally
Posted on Thursday August 15, 2019

IRVINE, CA, Aug. 15, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is preparing to announce a number of exciting new partnerships and acquisitions as the Company prepares for a significant growth in revenue and positive cash flow from operations in key markets globally. The Company will be taking corporate actions to fast track this growth, including compiling the Company financials over the next quarter to achieve compliance with its fully reporting status requirements.

Cannabis Science Successfully Completes European Headquarters and Operations Move to The Netherlands and Completes Shut Down of All Cannabis Science Europe GmbH Germany Operations
Posted on Monday August 05, 2019

IRVINE, CA, Aug. 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce the Company has successfully completed reorganization of its European business to better align with the requirements of its customers, partners, and stakeholders. This move is expected to help improve the efficiency and effectiveness of CBIS’ European operations, and provide the necessary infrastructure to manage supply-chain logistics, new product development, and revenue growth. The Company’s activities, including cultivation, extraction, and manufacturing, will be headquartered in The Netherlands while all former Germany operations have been dissolved.

Stock Market & Investing Books

Enter a stock symbol to view the stock details.